COQ8A (Coenzyme Q Kinase A), also known as ADCK3 (Atypical Kinase ADCK3), is a mitochondrial protein kinase belonging to the alpha-kinase family. Unlike classical protein kinases, COQ8A exhibits unique substrate specificity, primarily phosphorylating coenzyme Q biosynthesis intermediates rather than protein substrates. This kinase activity is essential for the final steps of CoQ10 (ubiquinone) synthesis, making COQ8A a critical determinant of mitochondrial electron transport chain efficiency[@stefely2016].
COQ8A (Coenzyme Q Kinase A), also known as ADCK3 (Atypical Kinase ADCK3), is a mitochondrial protein kinase belonging to the alpha-kinase family. Unlike classical protein kinases, COQ8A exhibits unique substrate specificity, primarily phosphorylating coenzyme Q biosynthesis intermediates rather than protein substrates. This kinase activity is essential for the final steps of CoQ10 (ubiquinone) synthesis, making COQ8A a critical determinant of mitochondrial electron transport chain efficiency[@stefely2016].
The human COQ8A gene is located on chromosome 14q24.3 and encodes a 645-amino acid protein with a mitochondrial targeting sequence and an atypical protein kinase domain. Biallelic pathogenic variants in COQ8A cause autosomal recessive cerebellar ataxia type 2 (ARCA2), a disorder characterized by childhood-onset cerebellar atrophy, exercise intolerance, and primary CoQ10 deficiency. Heterozygous variants may modify risk for Parkinson's disease (PD)[@lagoutte2010].
Molecular Function
Atypical Kinase Activity
COQ8A represents a distinct class of protein kinases[@xiao2012]:
Alpha-kinase family: Uses an alternative catalytic mechanism compared to conventional protein kinases
Substrate: Phosphorylates coenzyme Q biosynthesis intermediates, specifically COQ7 (also known as COQ8B in yeast)